Swiss Nordic Bio 2026

1 Oct 2026 | Zürich, Switzerland

All Participants - All

Participant search result

Paris Office

Paris, France

Global Emerging Markets 

zug, Switzerland

Private Investor, Zug 

Managing Director, Senior Advisor

Vontobel 

Partner

Atlas Capital Markets 

Venture Partner

Seventure Partners 

President

Zurich, Switzerland

MEDKAP Investors 

Co-Head Sustainable Healthcare Equity

Zurich, Switzerland

HSBC 

Investment Manager

UCEA Family Office Group 

Investor and founder

Nuglar, Switzerland

Alsteron AB 

Bavarian Capital 

Managing Partner

Zurich, Switzerland

4BIO Capital 

Advanced Therapies Lead

London, United Kingdom

Kerna Ventures 

Capitalist

Monte-Carlo, Monaco

Action Ventures 

I am in Guinness World Records because of my IPO.

I am in Guinness World Records because of my IPO.

Lead Investor

London, United Kingdom

Kerna Ventures 

Seed to series B investor focused on novel therapeutics.

Seed to series B investor focused on novel therapeutics.

Partnering Manager - Search & Evaluation

Lausanne, Switzerland

Debiopharm 

Venture Partner

Basel, Switzerland

VU Venture Partners 

Ricardo Gaminha Pacheco is an entrepreneurial Physician Executive dedicated to biomedical innovation, specialized in Innovative Medicines Development

Ricardo Gaminha Pacheco is an entrepreneurial Physician Executive dedicated to biomedical innovation, specialized in Innovative Medicines Development

Advisor to Life-Science Startups & Investors | Fundraising, GTM, Due Diligence

Zürich, Switzerland

Alpamed 

Scientist, founder & advisor. I help companies succeed in their fundraising: taking mandates to support your team on go-to-market, product dev and ops planning, then opening my investor network. Also supporting investors & family offices on due diligence.

Scientist, founder & advisor. I help companies succeed in their fundraising: taking mandates to support your team on go-to-market, product dev and ops planning, then opening my investor network. Also supporting investors & family offices on due diligence.

Executive Director

Zurich, Switzerland

BlackRock 

Kreos Capital (part of BlackRock) provides venture and growth debt with facilities from €5-150m

Kreos Capital (part of BlackRock) provides venture and growth debt with facilities from €5-150m

MedTech Specialist

Milano, Italy

XGen Venture 

MedTech Executive, Advisor and Investor with 20 years of international experience across Strategy & Execution, Global Marketing, Pricing, Business Development, M&A and Complex Cross-functional Projects.

MedTech Executive, Advisor and Investor with 20 years of international experience across Strategy & Execution, Global Marketing, Pricing, Business Development, M&A and Complex Cross-functional Projects.

Investment advisor

Zürich, Switzerland

Vesna Deeptech VC 

Advisor to Vesna VC, with a focus on pre-seed and seed-stage deeptech opportunities in the CEE region. Keen to connect with investors interested in the area.

Advisor to Vesna VC, with a focus on pre-seed and seed-stage deeptech opportunities in the CEE region. Keen to connect with investors interested in the area.